PAVmed vs QTREX Quantum
PAVM and QTEX side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PAVM and QTEX compare
QTREX Quantum keeps more of each dollar of sales as profit, with a net margin of −4574% compared with −10795% at PAVmed.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PAVM | QTEX |
|---|---|---|
| Size and price | ||
| Market cap | $13.0M | – |
| Share price | $1.63 | $1.25 |
| Change, 1 year | −85.9% | 27.6% |
| Change, 5 years | −99.9% | −56.9% |
| Beta (5Y) | 1.70 | 2.55 |
| Employees | 3 | 30 |
| StockData Score | ||
| Total score | 5 | 5 |
| Valuation score | 1 (better) | 0 |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 4 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 116× | – |
| P/B | 0.4× | – |
| FCF yield | −59.7% | – |
| Growth | ||
| Revenue growth (TTM) | −89.0% | – |
| Net income growth (TTM) | −117% | – |
| Profitability | ||
| Gross margin | −221% | 0.69% (better) |
| Operating margin | −23843% | −4714% (better) |
| Net margin | −10795% | −4574% (better) |
| FCF margin | −6948% | −3448% (better) |
| Return on equity | −33.3% (better) | −220% |
| Return on invested capital | −65.1% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Interest coverage | −3338.0× | – |
| Current ratio | 1.19 | 2.00 (better) |
| Altman Z-score | −11 | – |
| Piotroski F-score | 4 (better) | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 11.7% | 7.5% |
| Held by insiders | 23.5% | 27.8% |
| Insider net buying, 12 months | – | −$218K |
| Short interest, % of float | 0.21% | 13.8% |
Go deeper
- PAVM stock overview
- PAVM income statement
- PAVM valuation and score
- QTEX stock overview
- QTEX income statement
- QTEX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.